Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Veterinary Ramblings

Episode 105: Tackling Cancer with Salmonella

16 Nov 2023

Description

Join us as we delve into the world of cancer research with the incredible Doug Thamm. We kick things off by exploring Doug's groundbreaking study on utilizing salmonella to target cancer cells and discuss the evolution of this innovative approach.Moving through the episode, we get an inside look at the cancer service at Colorado State University, where Doug contributes to the 'One Cure' mission, revolutionizing cancer treatment in veterinary medicine.Ever wondered what a day in the life of a veterinary researcher looks like? We've got you covered! Doug gives us insights into his role at Colorado State University, including whether the iconic lab coat is still a part of his daily attire.In a touching segment, Doug shares his personal connection to cancer and how it led him to a fulfilling career in veterinary oncology. But it's not all about work! Discover Doug's life outside the lab, from his passion for speed skating to his lifelong love of making music.As an educator, Doug reflects on his teaching experiences and leaves us with a 60-Second CPD titled "YOU can successfully treat most mast cell tumors!" To cap it off, Doug leaves us with a reflection question that will have you pondering long after the episode ends.Β Don't miss this captivating conversation that seamlessly weaves science, personal stories, and thought-provoking insights. For a limited time only, head over to thamesmedical.com and use the code VR50 at the checkout for Β£50 off anything in the CAT+ range and get a free pair of CAT+ Supercuffs β˜… Support this podcast on Patreon β˜…

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
πŸ—³οΈ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.